New formulation of its widely-used U.S. market-leading PSMA PET imaging agentcombines thediagnostic performance of PYLARIFY® (piflufolastat F 18) ...

The pioneering procedure went 'extremely well', with patient Paul Buxton reporting feeling 'fantastic' just four days after the surgery which he did from 2,400 km away ...

A pioneering remote robotic surgery, the first of its kind in the UK, has been hailed as a significant medical "milestone" ...

Artificial intelligence has bounded into the mainstream, into personal lives, classroom assignments and work meetings — so it should be no surprise to find it in doctors’ offices and emergency ...

The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through a few drops of semen or blood in the long term. Prostate cancer is the most common ...

DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), ...

Our pilot study provides important evidence that microplastic exposure may be a risk factor for prostate cancer,” lead study ...

The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.

About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.

New study finds microplastics in 90% of prostate cancer tumors, with double the concentration in cancerous tissue compared to ...

PSMA-617 to androgen deprivation therapy (ADT) with androgen receptor pathway inhibitor (ARPI) bettered disease control in patients with metastatic hormone-sensitive prostate cancer (mHSPC), according ...